SEC Form 3 · accession 0001104659-18-057855
Y-mAbs Therapeutics, Inc. · YMAB
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gregory S Raskin
Director
Period of report
Sep 20, 2018
Accepted (ET)
Sep 20, 2018 · 6:02 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001722964
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 5,882 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Employee Stock Option (right to buy)F1 | $4.38 | holding | — | — | — | — | Oct 21, 2026 | Common Stock | 36,000 | — | D |
| Non-Employee Stock Option (right to buy)F2 | $11.16 | holding | — | — | — | — | Apr 24, 2028 | Common Stock | 32,000 | — | D |
Explanation of responses
- F1The stock option vested and became exercisable as to 33% of the shares subject to the option on October 21, 2016, and thereafter vests as to 1/36th of the shares in equal monthly installments, until such time as the option is 100% vested, subject to the Reporting Person being a service provider on each vesting date.
- F21/36th of the shares of the option to vest in equal monthly installments starting April 24, 2018 until such time as the option is 100% vested, subject to the Reporting Person continuing to be a service provider on each vesting date.